SBFM — Sunshine Biopharma Inc.
Fresh Supply424B filed ~14d ago🌀 Serial Splitter📄 Fresh Paper1-for-10,436 cumulative
XBRL EDGAR
424B filed ~14d ago
Case Notes
Sunshine Biopharma Inc. has 3 reverse splits on record — cumulative 1-for-10,436. Its share count grew 9.9% over the last twelve months per XBRL EDGAR data.
Most recent stress filing: 10-Q on 2026-05-14, flagging Capital need. 3 supply registrations (S-1/424B) landed in the last 12 months.
Registered shares exist to be sold — that is what the S-1 and 424B instruments document. In our research across this filing posture, freshly registered supply is the loaded state of the cycle: the paperwork has created the legal right to place shares into the market. That is not a prediction — it is what the filings say is possible.
Share Count Over Time
XBRL cover-page share counts from SEC EDGAR filings. Amber dashed lines mark reverse-split dates. 3 reverse splits on record.
Reverse Split Log
Each event consolidates shares — fewer shares, same market cap. Source: EDGAR corporate actions.
Cumulative effective ratio: 1-for-10,436— a share held at inception is now worth 1/10,436 of its original fraction.
Filing Stress Record
Stress-language flags extracted from SEC EDGAR 10-K/10-Q filings. Score 1–10 reflects language intensity.
| Date | Form | Score | Flags |
|---|---|---|---|
| 2024-08-19 | 10-Q | 1/10 | Capital need |
| 2024-11-06 | 10-Q | 1/10 | Capital need |
| 2025-04-02 | 10-K | 2/10 | Capital needListing compliance |
| 2025-05-16 | 10-Q | 1/10 | Capital need |
| 2025-08-13 | 10-Q | 1/10 | Capital need |
| 2025-11-14 | 10-Q | 1/10 | Capital need |
| 2026-04-06 | 10-K | 3/10 | Capital needSplit intentListing compliance |
| 2026-05-14 | 10-Q | 1/10 | Capital need |
Source: public EDGAR records.
424B Supply Pulse
Prospectus supplements (424B5) filed registering shares for resale — each bar is one month with a filing. Bars above average signal active distribution windows. Source: SEC EDGAR.